IL12 p40 Blocking Peptide for STJ501419 peptide (STJ504248)
SPECIFICATIONS
ImmunogenSynthetic peptide taken within amino acid region spanning 280-335 on rat Interleukin-12 subunit beta protein.
General Information
| Short Description | IL12 p40 Blocking Peptide for STJ501419 is synthetically produced from the 280-335 sequence and is suitable for use in western blot applications. |
| Applications | Immunodepletion/Immunocompetition |
| Note | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Product Properties
| Formulation | Liquid form at 2.5mg/ml concentration in PBS. Up to 5% DMSO can be added. Orders with >1mg can be supplied in lyophilized powder form, or in buffer of choice. |
| Storage Instruction | Store at-20ยฐC for long term storage. Avoid freeze-thaw cycles. |
Target Information
| Immunogen | Synthetic peptide taken within amino acid region spanning 280-335 on rat Interleukin-12 subunit beta protein. |
| Immunogen Region | 280-335 |
| Specificity | This blocking peptide is recommended for use in combination with IL12 p40 antibody, STJ501419 |
Additional Info
| Background | Cytokine that can act as a growth factor for activated T and NK cells, enhance the lytic activity of NK/lymphokine-activated killer cells, and stimulate the production of IFN-gamma by resting PBMC. |
Information sourced from Uniprot.org